These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 19474652

  • 41. Female genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections.
    Herold BC, Mesquita PM, Madan RP, Keller MJ.
    Am J Reprod Immunol; 2011 Mar; 65(3):325-33. PubMed ID: 21143689
    [Abstract] [Full Text] [Related]

  • 42. Toward early safety alert endpoints: exploring biomarkers suggestive of microbicide failure.
    Mauck CK, Lai JJ, Weiner DH, Chandra N, Fichorova RN, Dezzutti CS, Hillier SL, Archer DF, Creinin MD, Schwartz JL, Callahan MM, Doncel GF.
    AIDS Res Hum Retroviruses; 2013 Nov; 29(11):1475-86. PubMed ID: 23885658
    [Abstract] [Full Text] [Related]

  • 43. Trial shows Nonoxynol 9 efficacy is questionable.
    AIDS Alert; 1998 Oct; 13(10):117-20. PubMed ID: 11365872
    [Abstract] [Full Text] [Related]

  • 44. Appropriateness of hydroxyethylcellulose gel as a placebo control in vaginal microbicide trials: a comparison of the two control arms of HPTN 035.
    Richardson BA, Kelly C, Ramjee G, Fleming T, Makanani B, Roberts S, Musara P, Mkandawire N, Moench T, Coletti A, Soto-Torres L, Karim SA, HPTN 035 Study Team.
    J Acquir Immune Defic Syndr; 2013 May 01; 63(1):120-5. PubMed ID: 23334506
    [Abstract] [Full Text] [Related]

  • 45. Vaginal microbicides: a novel approach to preventing sexual transmission of HIV.
    Doncel G, Mauck C.
    Curr HIV/AIDS Rep; 2004 Apr 01; 1(1):25-32. PubMed ID: 16091220
    [Abstract] [Full Text] [Related]

  • 46. Topical microbicides: the time has come.
    Dhawan D, Keller M, Klotman ME.
    AIDS Read; 2006 Mar 01; 16(3):144-8, 155-8, 161; discussion 148, 156-7. PubMed ID: 16538955
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Update: barrier protection against HIV infection and other sexually transmitted diseases.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1993 Aug 06; 42(30):589-91, 597. PubMed ID: 8336689
    [Abstract] [Full Text] [Related]

  • 49. 'Ideal' microbicide may be best form of protection.
    AIDS Alert; 1999 Feb 06; 14(2):suppl 3-4. PubMed ID: 11366179
    [Abstract] [Full Text] [Related]

  • 50. Acceptability of optical coherence tomography and abstinence requirements among women participating in microbicide safety trials.
    Radecki Breitkopf C, Loza M, Vincent K, Moench T, Stanberry LR, Rosenthal SL.
    Sex Transm Dis; 2012 Jan 06; 39(1):28-31. PubMed ID: 22183842
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Acceptability of a non-woven device for vaginal drug delivery of microbicides or other active agents.
    Joanis CL, Hart CW.
    AIDS Behav; 2010 Jun 06; 14(3):600-6. PubMed ID: 20049522
    [Abstract] [Full Text] [Related]

  • 53. Impact of microbicides and sexually transmitted infections on mucosal immunity in the female genital tract.
    Keller MJ, Herold BC.
    Am J Reprod Immunol; 2006 Jun 06; 56(5-6):356-63. PubMed ID: 17076680
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Vaginal microbicides to prevent human immunodeficiency virus infection in women: perspectives on the female genital tract, sexual maturity and mucosal inflammation.
    Roberts L, Liebenberg L, Barnabas S, Passmore JA.
    Best Pract Res Clin Obstet Gynaecol; 2012 Aug 06; 26(4):441-9. PubMed ID: 22429786
    [Abstract] [Full Text] [Related]

  • 56. Acceptability of formulations and application methods for vaginal microbicides among drug-involved women: results of product trials in three cities.
    Hammett TM, Mason TH, Joanis CL, Foster SE, Harmon P, Robles RR, Finlinson HA, Feudo R, Vining-Bethea S, Jeter G, Mayer KH, Doherty-Iddings P, Seage GR.
    Sex Transm Dis; 2000 Feb 06; 27(2):119-26. PubMed ID: 10676980
    [Abstract] [Full Text] [Related]

  • 57. Nonoxyl-9 and women's struggle against HIV.
    Gilmour E.
    AIDS Anal Afr; 1996 Oct 06; 6(5):14. PubMed ID: 12347429
    [Abstract] [Full Text] [Related]

  • 58. Safety of single daily use for one week of C31G HEC gel in women.
    Ballagh SA, Baker JM, Henry DM, Archer DF.
    Contraception; 2002 Nov 06; 66(5):369-75. PubMed ID: 12443969
    [Abstract] [Full Text] [Related]

  • 59. Microbicidal spermicide or spermicidal microbicide?
    Gupta G.
    Eur J Contracept Reprod Health Care; 2005 Dec 06; 10(4):212-8. PubMed ID: 16448947
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.